IL311317A - A process for formulating preparations that include glucagon-like peptide-2 analogs (Glap-2) - Google Patents
A process for formulating preparations that include glucagon-like peptide-2 analogs (Glap-2)Info
- Publication number
- IL311317A IL311317A IL311317A IL31131724A IL311317A IL 311317 A IL311317 A IL 311317A IL 311317 A IL311317 A IL 311317A IL 31131724 A IL31131724 A IL 31131724A IL 311317 A IL311317 A IL 311317A
- Authority
- IL
- Israel
- Prior art keywords
- glp
- glucagon
- analogues
- peptide
- formulating compositions
- Prior art date
Links
- 229940121355 glucagon like peptide 2 (glp-2) analogues Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21196169 | 2021-09-10 | ||
PCT/EP2022/074961 WO2023036862A1 (en) | 2021-09-10 | 2022-09-08 | Process for formulating compositions comprising glucagon-like-peptide-2 (glp-2) analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
IL311317A true IL311317A (en) | 2024-05-01 |
Family
ID=77989732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL311317A IL311317A (en) | 2021-09-10 | 2022-09-08 | A process for formulating preparations that include glucagon-like peptide-2 analogs (Glap-2) |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR20240055083A (zh) |
CN (1) | CN118055757A (zh) |
AR (1) | AR127012A1 (zh) |
AU (1) | AU2022341538A1 (zh) |
CA (1) | CA3231402A1 (zh) |
IL (1) | IL311317A (zh) |
TW (1) | TW202327643A (zh) |
WO (1) | WO2023036862A1 (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1076066A1 (en) | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
SE518469C2 (sv) | 2001-02-12 | 2002-10-15 | Scania Cv Ab | Förfarande och system för fastställande av tankvolym |
KR101200227B1 (ko) | 2005-05-04 | 2012-11-13 | 질랜드 파마 에이/에스 | 글루카곤 유사 펩티드-2(glp-2) 유사체 |
EP3638291B1 (en) | 2017-06-16 | 2021-08-18 | Zealand Pharma A/S | Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues |
EP3628683A1 (en) | 2018-09-28 | 2020-04-01 | Zealand Pharma A/S | Formulations of glucagon-like-peptide-2 (glp-2) analogues |
EP3628682A1 (en) | 2018-09-28 | 2020-04-01 | Zealand Pharma A/S | Formulations of glucagon-like-peptide-2 (glp-2) analogues |
-
2022
- 2022-09-08 AU AU2022341538A patent/AU2022341538A1/en active Pending
- 2022-09-08 CN CN202280061254.7A patent/CN118055757A/zh active Pending
- 2022-09-08 KR KR1020247011554A patent/KR20240055083A/ko unknown
- 2022-09-08 IL IL311317A patent/IL311317A/en unknown
- 2022-09-08 AR ARP220102435A patent/AR127012A1/es unknown
- 2022-09-08 CA CA3231402A patent/CA3231402A1/en active Pending
- 2022-09-08 WO PCT/EP2022/074961 patent/WO2023036862A1/en active Application Filing
- 2022-09-08 TW TW111134097A patent/TW202327643A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20240055083A (ko) | 2024-04-26 |
WO2023036862A1 (en) | 2023-03-16 |
AR127012A1 (es) | 2023-12-06 |
AU2022341538A1 (en) | 2024-04-11 |
CN118055757A (zh) | 2024-05-17 |
CA3231402A1 (en) | 2023-03-16 |
TW202327643A (zh) | 2023-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018002326A (es) | Analogos novedosos de nucleosidos sustituidos en el anillo aromatico biciclico 6-6 para su uso como inhibidores de prmt5. | |
SG11201803699YA (en) | 7-(thiazol-5-yl) pyrrolopyrimidine compound as tlr7 agonist | |
IL281362A (en) | Formulations of glucagon-like peptide-2 (GLP-2) analogs | |
SG11202101881UA (en) | Process for preparing vaccine compositions | |
MX2010009854A (es) | Agente para liberacion de sustancia funcional. | |
NZ761619A (en) | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 | |
EA201791896A1 (ru) | Дезацетокситубулизин н и его аналоги | |
PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
IL285547A (en) | Long-acting glp-2 analogs | |
BR112019025195A8 (pt) | análogos do peptídeo gip de ação prolongada | |
BR112017018902A2 (pt) | processo | |
PL3356375T3 (pl) | Sposób odzyskiwania mieszaniny zawierającej pochodną kwasu (tio)fosforowego | |
IL311317A (en) | A process for formulating preparations that include glucagon-like peptide-2 analogs (Glap-2) | |
MX2017008074A (es) | DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß). | |
HUE061427T2 (hu) | Ipari eljárás nagytisztaságú ösztetrol hatóanyag elõállítására | |
ZA202105478B (en) | Compositions for replacing chemical surfactants | |
GB2614494B (en) | Process for preparing (3a,5a)-3-hydroxy-3-methyl-pregnan-20-one (ganaxolone) | |
TN2012000436A1 (en) | Agomelatine hydrobromide hydrate and preparation thereof | |
MX2018005134A (es) | Formulacion de factor viii (fviii). | |
GB202009392D0 (en) | Process for preparing surfactant | |
IL291634A (en) | Process for the preparation of 1,1'-disulfandylbis(4-fluoro-2-methyl-5-nitrobenzene) | |
GB202009388D0 (en) | Surfactant preparation process | |
RS65314B1 (sr) | Smeša koja sadrži kaliksarene, postupak za njihovu proizvodnju i njihova upotreba za pripremu kompozicija deterdženta za maziva | |
GB202315018D0 (en) | Immunogenic compositions | |
GB202204482D0 (en) | Immunogenic compositions |